BioVectra Expands Role with Keryx
Charlottetown drug manufacturer BioVectra Inc. announced Thursday it has signed a manufacturing agreement with Boston-based Keryx Biopharmaceuticals.
BioVectra will supply Keryx with a key ingredient for its Auryxia tablets, a medicine that treats people with chronic kidney disease.
BioVectra plans to manufacture and supply Ferric Citrate, the active pharmaceutical ingredient, or API, in